|4Jun 23, 4:57 PM ET

Morris Gabriel S 4

4 · Immix Biopharma, Inc. · Filed Jun 23, 2025

Insider Transaction Report

Form 4
Period: 2025-06-20
Morris Gabriel S
DirectorCFO
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-06-20+340,000340,000 total
    Exercise: $2.24Exp: 2035-06-20Common Stock (340,000 underlying)
Holdings
  • Common Stock

    (indirect: See footnote)
    24,141
  • Common Stock

    288,059
  • Common Stock

    (indirect: See footnote)
    270,844
Footnotes (3)
  • [F1]Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
  • [F2]Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
  • [F3]The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4